D.C. medical cannabis program sets another high in June as sales top $10.3 million D.C.’s medical cannabis program posted another strong month in June, with total registered resident patients rising to 131,133 and overall program sales reaching $10.38 million. Resident patient purchases remained steady, while reciprocity and temporary-patient activity continued to drive a significant share of the market. Enforcement also picked up, with 27 inspections, one violation, and two unlicensed facilities closed.
- Catch up on the July 15th disposition or subscribe to a paying membership to receive exclusive summaries of Board meetings and see our map of pending cannabis businesses in D.C.
- ABC Board will observe summer recess from August 13 – September 15.
Virginia Public Health Council to help shape adult-use cannabis regulations
Virginia’s Cannabis Public Health Advisory Council is advising regulators on product safety, public education, and cannabis policy as the Commonwealth develops rules for its adult-use market. Licensed retail sales are scheduled to begin July 1, 2027.
Maryland Regulators Propose Rule Changes for Licensees, Packaging, and New Cannabis Products
The Maryland Cannabis Administration is seeking public comment on a broad set of proposed rule changes that would affect licensees across the state, with feedback due July 27, 2026. The package would give conditional licensees more time to launch, add new labor and compliance standards, update packaging and labeling rules, and clarify enforcement procedures as Maryland continues refining its cannabis market.
ICYMI: D.C. rejects DC Dank appeal and Virginia seeks industry input on retail rules
East Coast Roundup
Syracuse, New York, is offering summer-school style training to help people prepare for jobs in New York’s growing cannabis industry.
Vermont police are asking volunteers to consume cannabis so officers can practice spotting signs of impairment.
New York is moving to make landlords deal with illegal, padlocked cannabis shops rather than leaving properties in limbo.
A Massachusetts effort to repeal cannabis legalization has qualified for the November ballot, putting the state’s adult-use law back in play.
Culture & More
Drug testing and pharmaceutical interests are arguing that President Trump’s rescheduling move could increase cannabis abuse.
A new study suggests THC and CBD may help treat agitation in patients with dementia.
Around the Country
Michigan officials say GCM Waypoint will surrender its processor license and permanently shut down under the state’s cannabis rules.
The Colorado Marijuana Enforcement Division announced its 2026 summer rulemaking and annual fee review, including a proposed 2.4% fee increase, several new or revised fees, and broader rule updates on testing, transfers, and license privileges.
Idaho’s medical cannabis initiative failed to qualify for the general election ballot.
From the swamp
The federal cannabis rescheduling hearing has wrapped up, and the DEA judge has outlined next steps.
Cannabis companies donated $11.5 million to a Trump-linked PAC last month, setting a new campaign finance record.
The Senate reintroduced the Cannabis Administration and Opportunity Act, a bill that would fully deschedule cannabis at the federal level and create a national regulatory framework with expungement and social equity provisions.
